Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-21-003283
Filing Date
2021-02-25
Accepted
2021-02-25 16:04:12
Documents
116
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akba-20201231.htm   iXBRL 10-K 3945604
2 EX-4.6 exhibit46b-descriptionofth.htm EX-4.6 25210
3 EX-10.8 exhibit108-sixthamendmentt.htm EX-10.8 47518
4 EX-10.19 exhibit1019-directorcomppr.htm EX-10.19 26619
5 EX-10.57 exhibit1057-keryxxsiegfrie.htm EX-10.57 14034
6 EX-10.58 exhibit105eryxxsiegfriedms.htm EX-10.58 13848
7 EX-10.59 exhibit1059d-finalredacted.htm EX-10.59 36328
8 EX-21.1 exhibit211-subsidiaries.htm EX-21.1 8237
9 EX-23.1 exhibit231-eyconsent.htm EX-23.1 8204
10 EX-31.1 akbaex311.htm EX-31.1 11000
11 EX-31.2 akbaex312.htm EX-31.2 11025
12 EX-32.1 akbaex321.htm EX-32.1 8286
18 akba-20201231_g1.jpg GRAPHIC 505677
  Complete submission text file 0001628280-21-003283.txt   18297473

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20201231.xsd EX-101.SCH 118446
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20201231_cal.xml EX-101.CAL 173649
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20201231_def.xml EX-101.DEF 666445
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20201231_lab.xml EX-101.LAB 1273229
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20201231_pre.xml EX-101.PRE 894995
19 EXTRACTED XBRL INSTANCE DOCUMENT akba-20201231_htm.xml XML 2817793
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36352 | Film No.: 21680196
SIC: 2834 Pharmaceutical Preparations